| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3M | — | +22.4% |
| Cost of Revenue | $1.3M | — | +2.7% |
| Gross Profit | $971K | — | +64.9% |
| R&D Expense | $7K | — | -81.4% |
| SG&A Expense | $213K | — | -25.8% |
| Operating Income | $191K | — | +140.3% |
| Net Income | $241K | — | +151.0% |
| EPS (Basic) | $0.02 | — | +150.0% |
| EPS (Diluted) | $0.02 | — | +150.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.9M | +81.0% | +17.3% |
| Accounts Receivable | $869K | -5.4% | — |
| Current Assets | $3.9M | +43.4% | +7.7% |
| Total Assets | $3.9M | +42.3% | +6.0% |
| Current Liabilities | $1.6M | +134.5% | +25.0% |
| Total Liabilities | $1.6M | +134.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.4M | — | +760.7% |
| Financing Cash Flow | -$54K | — | +13.8% |
| +25.0% |
| Stockholders' Equity | $2.4M | +12.6% | -3.8% |